Potential medication errors in the context of benefit risk balance and risk minimisation measures - Scientific guideline

This document focuses on the impact of potential medication errors on the benefit-risk balance of medicinal products introducing changes in relation to an authorised/established product containing the same active substance.

Keywords: Medication error, similar medicinal products, reference product, product confusion, error prevention